95 research outputs found
Coping with Illness: Insight from the Bhagavad Gita
The Shrimad Bhagavad Gita enlightens everyone on how to cope up with various situations in life. It uses the conversation between Lord Krishna and Arjuna to highlight initial negative coping mechanisms exhibited by the latter. It goes on to showcase positive coping skills suggested by Lord Krishna and implemented by Arjuna. The Bhagavad Gita, through this case-based methodology, teaches us how to cope with a demanding situation. Diabetes is a lifestyle disease, which warrants a thorough change in one\u27s lifestyle, including changes in basic activities such as diet and exercise. This brief communication utilizes the teachings of Bhagavad Gita to help in coping with illness, especially chronic illness such as diabetes. The article cites verses from the Bhagavad Gita to show how one may cope with the stress of illness such as diabetes
Natural History Of Implantable Cardioverter-Defibrillator Implanted At Or After The Age Of 70 Years In A Veteran Population A Single Center Study
Background:
The median age of patients in major Implantable Cardioverter-defibrillator (ICD)trials (MUSTT, MADIT-I, MADIT-II, and SCD-HeFT) was 63-67 years; with only 11% ≥70 years. There is little follow-up data on patients over 70 years of age who received an ICD for primary/secondary prevention of sudden cardiac death, particularly for veterans.
Objective:
The aim of this study was to study the natural history of ICD implantation for veterans over 70 years of age.
Methods:
We retrospectively reviewed single center ICD data in 216 patients with a mean age at implantation 76 ± 4 years. The ICD indication was primary prevention in 161 patients and secondary prevention in 55 patients. The ICD indication was unavailable in 4 patients.
Results:
Mean duration of follow up was 1686 ± 1244 days during which 114 (52%) patients died. Of these, 31% died without receiving any appropriate ICD therapy. Overall, 60/216 (28%) received appropriate therapy and 28/216 (13%) received inappropriate therapy. Patients who had ICD implantation for secondary prophylaxis had statistically more (p= 0.02) appropriate therapies compared to patients who had ICD implantation for primary prevention. Indication for implantation and hypertension predicted appropriate therapy, while age at the time of implantation and presence of atrial fibrillation predicted inappropriate therapies. Overall, 7.7% had device related complications.
Conclusions:
Although 28% septuagenarians in this study received appropriate ICD therapy, they had high rates of mortality, inappropriate therapy, and device complications. ICD implantation in the elderly merits individualized consideration, with higher benefit for secondary prevention
Prognostic factors associated with small for gestational age babies in a tertiary care hospital of Western Nepal:A cross-sectional study
Structure of S. aureus HPPK and the Discovery of a New Substrate Site Inhibitor
The first structural and biophysical data on the folate biosynthesis pathway enzyme and drug target, 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (SaHPPK), from the pathogen Staphylococcus aureus is presented. HPPK is the second essential enzyme in the pathway catalysing the pyrophosphoryl transfer from cofactor (ATP) to the substrate (6-hydroxymethyl-7,8-dihydropterin, HMDP). In-silico screening identified 8-mercaptoguanine which was shown to bind with an equilibrium dissociation constant, Kd, of ∼13 µM as measured by isothermal titration calorimetry (ITC) and surface plasmon resonance (SPR). An IC50 of ∼41 µM was determined by means of a luminescent kinase assay. In contrast to the biological substrate, the inhibitor has no requirement for magnesium or the ATP cofactor for competitive binding to the substrate site. The 1.65 Å resolution crystal structure of the inhibited complex showed that it binds in the pterin site and shares many of the key intermolecular interactions of the substrate. Chemical shift and 15N heteronuclear NMR measurements reveal that the fast motion of the pterin-binding loop (L2) is partially dampened in the SaHPPK/HMDP/α,β-methylene adenosine 5′-triphosphate (AMPCPP) ternary complex, but the ATP loop (L3) remains mobile on the µs-ms timescale. In contrast, for the SaHPPK/8-mercaptoguanine/AMPCPP ternary complex, the loop L2 becomes rigid on the fast timescale and the L3 loop also becomes more ordered – an observation that correlates with the large entropic penalty associated with inhibitor binding as revealed by ITC. NMR data, including 15N-1H residual dipolar coupling measurements, indicate that the sulfur atom in the inhibitor is important for stabilizing and restricting important motions of the L2 and L3 catalytic loops in the inhibited ternary complex. This work describes a comprehensive analysis of a new HPPK inhibitor, and may provide a foundation for the development of novel antimicrobials targeting the folate biosynthetic pathway
Neurodevelopmental disorders in children aged 2-9 years: Population-based burden estimates across five regions in India.
BACKGROUND: Neurodevelopmental disorders (NDDs) compromise the development and attainment of full social and economic potential at individual, family, community, and country levels. Paucity of data on NDDs slows down policy and programmatic action in most developing countries despite perceived high burden. METHODS AND FINDINGS: We assessed 3,964 children (with almost equal number of boys and girls distributed in 2-<6 and 6-9 year age categories) identified from five geographically diverse populations in India using cluster sampling technique (probability proportionate to population size). These were from the North-Central, i.e., Palwal (N = 998; all rural, 16.4% non-Hindu, 25.3% from scheduled caste/tribe [SC-ST] [these are considered underserved communities who are eligible for affirmative action]); North, i.e., Kangra (N = 997; 91.6% rural, 3.7% non-Hindu, 25.3% SC-ST); East, i.e., Dhenkanal (N = 981; 89.8% rural, 1.2% non-Hindu, 38.0% SC-ST); South, i.e., Hyderabad (N = 495; all urban, 25.7% non-Hindu, 27.3% SC-ST) and West, i.e., North Goa (N = 493; 68.0% rural, 11.4% non-Hindu, 18.5% SC-ST). All children were assessed for vision impairment (VI), epilepsy (Epi), neuromotor impairments including cerebral palsy (NMI-CP), hearing impairment (HI), speech and language disorders, autism spectrum disorders (ASDs), and intellectual disability (ID). Furthermore, 6-9-year-old children were also assessed for attention deficit hyperactivity disorder (ADHD) and learning disorders (LDs). We standardized sample characteristics as per Census of India 2011 to arrive at district level and all-sites-pooled estimates. Site-specific prevalence of any of seven NDDs in 2-<6 year olds ranged from 2.9% (95% CI 1.6-5.5) to 18.7% (95% CI 14.7-23.6), and for any of nine NDDs in the 6-9-year-old children, from 6.5% (95% CI 4.6-9.1) to 18.5% (95% CI 15.3-22.3). Two or more NDDs were present in 0.4% (95% CI 0.1-1.7) to 4.3% (95% CI 2.2-8.2) in the younger age category and 0.7% (95% CI 0.2-2.0) to 5.3% (95% CI 3.3-8.2) in the older age category. All-site-pooled estimates for NDDs were 9.2% (95% CI 7.5-11.2) and 13.6% (95% CI 11.3-16.2) in children of 2-<6 and 6-9 year age categories, respectively, without significant difference according to gender, rural/urban residence, or religion; almost one-fifth of these children had more than one NDD. The pooled estimates for prevalence increased by up to three percentage points when these were adjusted for national rates of stunting or low birth weight (LBW). HI, ID, speech and language disorders, Epi, and LDs were the common NDDs across sites. Upon risk modelling, noninstitutional delivery, history of perinatal asphyxia, neonatal illness, postnatal neurological/brain infections, stunting, LBW/prematurity, and older age category (6-9 year) were significantly associated with NDDs. The study sample was underrepresentative of stunting and LBW and had a 15.6% refusal. These factors could be contributing to underestimation of the true NDD burden in our population. CONCLUSIONS: The study identifies NDDs in children aged 2-9 years as a significant public health burden for India. HI was higher than and ASD prevalence comparable to the published global literature. Most risk factors of NDDs were modifiable and amenable to public health interventions
Recommended from our members
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation
Comparative evaluation of effect of metal primer and sandblasting on the shear bond strength between heat cured acrylic denture base resin and cobalt-chromium alloy: An in vitrostudy
Aims: The aim of this study was to evaluate the effect of metal primers and sandblasting on the shear bond strength (SBS) of heat cured acrylic denture base resin to cobalt-chromium (Co-Cr) alloy. Materials and Methods: A total number of 40 disk shaped wax patterns (10 mm in diameter and 2 mm in thickness) were cast in Co-Cr alloy. Samples were divided into 4 groups depending on the surface treatment received. Group 1: No surface treatment was done and acts as control group. Group 2: Only sandblasting was done. Group 3: Only metal primer was applied. Group 4: Both metal primer and sandblasting were done. After surface treatment samples had been tested in Universal Testing Machine at crosshead speed of 0.5 mm/min in shear mode and scanning, electron microscope evaluation was done to observe the mode of failure. Statistical Analysis: All the observations obtained were analyzed statistically using software SPSS version 17; one-way analysis of variance (ANOVA) and post-hoc Tukey test were applied. Results: The one-way ANOVA indicated that SBS values varied according to type of surface treatment done. The SBS was highest (18.70 ± 1.2 MPa) when both sandblasting and metal primer was done when compared with no surface treatment (2.59 ± 0.32 MPa). Conclusions: It could be concluded that the use of metal primers along with sandblasting significantly improves the bonding of heat cured acrylic denture base resin with the Co-Cr alloy
Implementation of hop field neural network model in the area of associative memory
The human memory has its ability to learn about many new things without necessarily forgetting them, learnt in the past. Exactly the same can be thought about the Artificial
Neural Networks system, How can its learning system remain responsive in response to significant input, yet remain stable in response to irrelevant input? How does the system
retain previously learnt information while continuing to learn about new information. This paper attempts to address the theory and implementation of Hopfield Neural Network in
the area of Associative Memory(AM). There are three types of Associative Memory: Hetero-associative Memory, Interpolative Memory and Auto-associative Memory. Human
memory works on the basis of partial knowledge of its contents and or association with other information. This may be called as “Content-Addressible Memory”. We provide a
small part of input pattern to the system, the net or by self excitation the whole pattern will be regenerated. Neural network simulations have allowed researchers to study how and under what conditions such studies are that associative memory can do better in the presence of a certain level of internal noise or with certain level of forgetfulness, The system, distributed as one memory is distributed over many synapses, superimposed because one synapse can be involved in several memories and robust because altering a few synapses degrade the performance by very little
Facial Measurements and Their Correlation with Vertical Dimension of Occlusion in Dentate Subjects: An Anthropometric Analysis
Introduction: In the field of prosthodontics, there lies a delicate
balance between the preservation of supporting structures
and the restoration of physiological function while providing
complete denture prostheses to completely edentulous
patients. A good prosthesis requires appropriate recording of
the proper maxillo-mandibular relationship, including the vertical
dimension of occlusion, which is a crucial step in complete
denture fabrication. The reliability of anthropometric methods to
determine the vertical dimension of occlusion has been widely
discussed in the literature.
Aim: To evaluate the correlation of various facial measurements
with the vertical dimension of occlusion in dentate subjects.
Materials and Methods: This cross-sectional study was
conducted in the Department of Prosthodontics at a Dental College
in Ambala district of Haryana, India, from February 2021 to July
2023. A total of 100 subjects (50 females and 50 males) within the
age range of 20-35 years were selected. Five facial parameters
were selected to correlate with the vertical dimension of occlusion:
the distance from glabella to subnasion, the distance from the
outer canthus of one eye to the inner canthus of the other eye, the
distance from the outer canthus to the rima oris, the distance from
the outer canthus to the External Auditory Meatus (EAM) on the
left side of the face, and the Interpupillary Distance (IPD). Facial
measurements were recorded using a digital vernier calliper,
while IPD was recorded using a PD ruler. Each measurement
was made three times and recorded by a single operator. Once
recorded, all the measurements were tabulated and subjected to
statistical analysis using the Pearson’s correlation coefficient test.
Regression analysis was also conducted to formulate a regression
equation for determining the vertical dimension of occlusion.
Results: The mean Vertical Dimension of Occlusion (VDO) for
males was 59.29±6.48 mm, and for females, it was 52.34±5.92
mm. The results showed a positive and significant (p-value<0.05)
correlation between the vertical dimension of occlusion and
facial measurements such as glabella to subnasion (p-value
for males: 0.001, p-value for females: <0.001), outer canthus
to inner canthus (p-value for males: 0.01, p-value for females:
<0.001), outer canthus to rima oris (p-value for males: <0.001,
p-value for females: <0.001), and outer canthus to EAM (p-value
for males: 0.007, p-value for females: 0.001) in both males and
females. However, there was no significant correlation between
IPD and VDO (p-value for males: 0.296, p-value for females:
0.66) in both genders.
Conclusion: It can be concluded that facial measurements
could be taken into consideration for determining the vertical
dimension of occlusion in completely edentulous patients in
conjunction with other reliable methods
- …